Amylyx Pharmaceuticals, Inc. (AMLX), a Massachusetts-based biopharmaceutical company, Friday announced the pricing of an underwritten ...

Nonfarm payrolls increased by 256,000 jobs last month after rising by a downwardly revised 212,000 in November, while the unemployment rate fell to 4.1% from 4.2%, Reuters reported this morning.

The health and wellness world never stands still. Even as interest in well-being reaches all-time highs, there are fresh trends on the horizon, and TruLife Distribution founder and CEO Brian Gould ...

For more information, or to register for this event, visit The New Era of CDx in Oncology: Adapting Clinical Research Strategy to Evolving Regulations.

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a public offering ...

Amylyx Pharmaceuticals prices public offering of common stock at $3.50 per share, aiming to raise $60M for commercialization and pipeline programs.

Dan Monahan, the exec who led Otsuka’s commercialization of Rexulti and Abilify Maintena, is taking command of the launch of ...

City Therapeutics broke cover in October with a $135 million Series A and the opportunity for executive chairman John ...

Pharmaceuticals announced that it has commenced an underwritten public offering of shares of its common stock. Amylyx intends to ...

Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares are being ...